Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
FONR 
Fonar Corporation (FONR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/10/2025: FONR (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit 4.55% | Avg. Invested days 33 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/10/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 93.69M USD | Price to earnings Ratio 11.9 | 1Y Target Price - |
Price to earnings Ratio 11.9 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1 | 52 Weeks Range 12.00 - 18.68 | Updated Date 06/29/2025 |
52 Weeks Range 12.00 - 18.68 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.25 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 8.19% | Operating Margin (TTM) 13.48% |
Management Effectiveness
Return on Assets (TTM) 3.54% | Return on Equity (TTM) 6.91% |
Valuation
Trailing PE 11.9 | Forward PE - | Enterprise Value 78089814 | Price to Sales(TTM) 0.91 |
Enterprise Value 78089814 | Price to Sales(TTM) 0.91 | ||
Enterprise Value to Revenue 0.76 | Enterprise Value to EBITDA 3.37 | Shares Outstanding 6168460 | Shares Floating 6030734 |
Shares Outstanding 6168460 | Shares Floating 6030734 | ||
Percent Insiders 2.45 | Percent Institutions 49.08 |
Upturn AI SWOT
Fonar Corporation
Company Overview
History and Background
Fonar Corporation was founded in 1978 by Dr. Raymond Damadian, a pioneer in MRI technology. Fonar developed the first commercial MRI scanner and has focused on upright MRI systems since.
Core Business Areas
- MRI Scanner Manufacturing: Designs, manufactures, and markets MRI scanners, primarily upright MRI systems.
- MRI Scanner Service and Maintenance: Provides service, maintenance, and repair for its installed base of MRI scanners.
- Management and Diagnostic Services: Manages diagnostic imaging facilities and provides diagnostic services.
Leadership and Structure
Dr. Raymond Damadian is the Chairman and Founder. The company has a traditional corporate structure with functional departments.
Top Products and Market Share
Key Offerings
- Upright MRI Scanners: Fonar's primary product is its line of Upright MRI scanners, allowing patients to be scanned in weight-bearing positions. Market share data is difficult to obtain precisely for upright MRI, but they are a niche player. Competitors include Siemens, GE Healthcare, and Philips who offer traditional MRI systems. Revenue from Upright MRI scanners makes up the majority of Fonar's revenue.
- FONAR UPRIGHT MULTIPOSITIONAL MRI: The FONAR UPRIGHT MULTIPOSITIONAL MRI is a standup open MRI. Market share data is difficult to obtain precisely for upright MRI, but they are a niche player. Competitors include Siemens, GE Healthcare, and Philips who offer traditional MRI systems.
Market Dynamics
Industry Overview
The MRI market is driven by aging populations, increasing prevalence of chronic diseases, and technological advancements. Competition is intense, with major players investing heavily in R&D.
Positioning
Fonar occupies a niche position in the MRI market with its upright MRI technology. Its competitive advantage lies in its ability to provide weight-bearing imaging.
Total Addressable Market (TAM)
The global MRI market is projected to reach hundreds of billions of USD. Fonar's TAM is a fraction of that total, focused on the upright/open MRI segment.
Upturn SWOT Analysis
Strengths
- Proprietary Upright MRI Technology
- Established Brand in Niche Market
- Strong Service and Maintenance Revenue
- Founder Led
Weaknesses
- Limited Market Share Compared to Major Players
- High Reliance on Upright MRI Market
- Smaller R&D Budget Compared to Competitors
- Single Product Focus
Opportunities
- Expanding into New Geographic Markets
- Developing New Applications for Upright MRI
- Partnerships with Healthcare Providers
- Increasing Demand for Personalized Medicine
Threats
- Intense Competition from Major MRI Manufacturers
- Technological Advancements Rendering Upright MRI Obsolete
- Changing Healthcare Regulations
- Economic Downturn Impacting Capital Spending
Competitors and Market Share
Key Competitors
- SIEMENS (SIEGY)
- GE Healthcare (GE)
- Philips (PHG)
Competitive Landscape
Fonar's advantage is its upright MRI technology, but it faces significant competition from larger, more diversified players in the MRI market.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been moderate, driven primarily by sales and service of its Upright MRI systems.
Future Projections: Future projections are dependent on the company's ability to expand its market reach and innovate its product offerings. Please consult analyst estimates for future growth.
Recent Initiatives: Recent initiatives likely include efforts to expand distribution and improve the performance of its Upright MRI systems.
Summary
Fonar Corporation is a niche player in the MRI market with its unique upright MRI technology. While it has a strong brand and proprietary technology, it faces significant competition from larger companies. Its success depends on its ability to expand its market reach and continue innovating. The company should look out for technological changes that could impact the relevance of its upright MRI technology.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Financial News Outlets
- Market Research Reports
- SEC Filings
Disclaimers:
The information provided is for informational purposes only and should not be construed as investment advice. Market share data is estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Fonar Corporation
Exchange NASDAQ | Headquaters Melville, NY, United States | ||
IPO Launch date 1987-01-01 | Chairman, President, CEO & Treasurer Mr. Timothy R. Damadian M.D. | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 520 | Website https://www.fonar.com |
Full time employees 520 | Website https://www.fonar.com | ||
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. The company offers Upright MRI scanner, allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.